Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Dr. Jain brings extensive experience in the biotech and pharma sectors and has been instrumental in driving innovation, vaccine development, and healthcare advancement
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
